COVID19. Coronavirus infection, unspecified
Conditions
Interventions
Intervention group: Patients with COVID-19 undergo hemoperfusion..
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with severe progressive pulmonary involvement Have a positive PCR test Patients who are currently under mechanical ventilation or will need it in the near future.
Exclusion criteria
Exclusion criteria: Patients with shock symptoms Patients with multiple organ failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality. Timepoint: End of study. Method of measurement: Patient file.;Number of hospitalization days. Timepoint: End of study. Method of measurement: Patient file.;CT scan indexes. Timepoint: Before the start of the study and the first day after hemoperfusion. Method of measurement: CT scan of the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Temperature. Timepoint: Days 1, 3, 7 and 12. Method of measurement: Thermometer.;O2 sat. Timepoint: Days 1, 3, 7 and 12. Method of measurement: Pulse oximetry.;WBC. Timepoint: Days 1, 3, 7 and 12. Method of measurement: Blood test.;Lym. Timepoint: Days 1, 3, 7 and 12. Method of measurement: Blood test.;Ferritin. Timepoint: Days 1, 3, 7 and 12. Method of measurement: Blood test.;Ast, Alt , Alkp. Timepoint: Days 1, 3, 7 and 12. Method of measurement: Blood test.;Mechanical ventilation. Timepoint: Before the intervention and the first dose after hemoperfusion. Method of measurement: Patient prognosis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Raesi
Shahre-kord University of Medical Sciences
Outcome results
None listed